Development of sclerosing cholangitis during long-term interferon-alpha-2b therapy

被引:1
|
作者
Meuthen, I
Bohcken, L
机构
[1] Holweide Hosp, Cologne City Clin, Med Clin, D-51058 Cologne, Germany
[2] Holweide Hosp, Cologne City Clin, Urol Clin, D-51058 Cologne, Germany
关键词
D O I
10.1055/s-2007-1004336
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:S58 / S58
页数:1
相关论文
共 50 条
  • [21] INTERFERON-ALPHA-2B THERAPY AND PREGNANCY - REPORT OF A CASE OF ESSENTIAL THROMBOCYTHEMIA
    PARDINI, S
    DORE, F
    MURINEDDU, M
    BONTIGLI, S
    LONGINOTTI, M
    GRIGLIOTTI, B
    SPANO, B
    AMERICAN JOURNAL OF HEMATOLOGY, 1993, 43 (01) : 78 - 78
  • [22] EFFECTS OF RECOMBINANT INTERFERON-ALPHA-2B THERAPY IN PATIENTS WITH PROGRESSIVE MS
    KINNUNEN, E
    TIMONEN, T
    PIRTTILA, T
    KALLIOMAKI, P
    KETONEN, L
    MATIKAINEN, E
    SEPPONEN, R
    JUNTUNEN, J
    ACTA NEUROLOGICA SCANDINAVICA, 1993, 87 (06): : 457 - 460
  • [23] LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC HEPATITIS-C TREATED WITH DIFFERENT DOSES OF INTERFERON-ALPHA-2B
    SARACCO, G
    ROSINA, F
    ABATE, ML
    CHIANDUSSI, L
    GALLO, V
    CERUTTI, E
    DINAPOLI, A
    SOLINAS, A
    DEPLANO, A
    TOCCO, A
    COSSU, P
    CHIEN, D
    KUO, G
    POLITO, A
    WEINER, AJ
    HOUGHTON, M
    VERME, G
    BONINO, F
    RIZZETTO, M
    HEPATOLOGY, 1993, 18 (06) : 1300 - 1305
  • [24] Comparison of long-term effects of lymphoblastoid interferon alpha and recombinant interferon alpha-2a therapy in patients with chronic hepatitis B
    Lin, SM
    Tai, DI
    Chien, RN
    Sheen, LS
    Chu, CM
    Liaw, YF
    JOURNAL OF VIRAL HEPATITIS, 2004, 11 (04) : 349 - 357
  • [25] CHEMOIMMUNOTHERAPY FOR PROPHYLAXIS OF RECURRENCE IN SUPERFICIAL BLADDER-CANCER - INTERFERON-ALPHA-2B VERSUS INTERFERON-ALPHA-2B WITH EPIRUBICIN
    FERRARI, P
    CASTAGNETTI, G
    POLLASTRI, CA
    FERRARI, G
    TAVONI, F
    GRASSI, D
    ANTI-CANCER DRUGS, 1992, 3 : 25 - 27
  • [26] Recurrence of sclerosing pancreato-cholangitis (pseudo-PSC) during long-term corticosteroid therapy.
    Abei, M
    Seo, E
    Kurosawa, T
    Fukuda, K
    Tanaka, N
    GASTROENTEROLOGY, 2001, 120 (05) : A388 - A389
  • [27] TREATMENT OF A SEVERE HEMANGIOMA WITH INTERFERON-ALPHA-2B
    MORTUREUX, P
    PEDESPAN, JM
    GRESELLE, JF
    DEVARS, F
    MALEVILLE, J
    TAIEB, A
    ARCHIVES DE PEDIATRIE, 1995, 2 (03): : 237 - 240
  • [28] Primary sclerosing cholangitis: Conventional and quantitative liver function tests during long-term therapy with ursodeoxycholic acid
    vonSchonfeld, J
    Zotz, R
    Mahl, M
    Beste, M
    Breuer, N
    Goebell, H
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1996, 34 (02): : 123 - 127
  • [30] LONG-TERM OUTCOME OF INTERFERON-ALPHA THERAPY FOR CHRONIC HEPATITIS-B
    DIBISCEGLIE, AM
    JOURNAL OF HEPATOLOGY, 1995, 22 : 65 - 67